Stefanie Deuster

Tolerability, safety, pharmacokinetics, and efficacy of doxorubicin-loaded anti-EGFR immunoliposomes in advanced solid tumours: a phase 1 dose-escalation study

Christoph Mamot, Reto Ritschard, Andreas Wicki et al. · The Lancet Oncology · 2012 · 238 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Improved Muscle Function in Duchenne Muscular Dystrophy through L-Arginine and Metformin: An Investigator-Initiated, Open-Label, Single-Center, Proof-Of-Concept-Study

Patricia Hafner, Beat Erne, Maurice Schmid et al. · PLoS ONE · 2016 · 77 citations · Full text

Life Sciences, Biochemistry, Neurology +17

Implementation of treatment guidelines to support judicious use of antibiotic therapy

Stefanie Deuster, I. Roten, S. Muehlebach · Journal of Clinical Pharmacy and Therapeutics · 2009 · 56 citations

Pharmacy, Hospital Pharmacy, Pharmacotherapy +17

Large-scale manufacturing of GMP-compliant anti-EGFR targeted nanocarriers: Production of doxorubicin-loaded anti-EGFR-immunoliposomes for a first-in-man clinical trial

Andreas Wicki, Reto Ritschard, Uli Loesch et al. · International Journal of Pharmaceutics · 2015 · 43 citations

Pharmacy, Molecular Pharmaceutics, Pharmaceutics +17

A multicenter phase II trial of anti-EGFR-immunoliposomes loaded with doxorubicin in patients with advanced triple negative breast cancer

Christoph Mamot, Andreas Wicki, Ursula Hasler-Strub et al. · Scientific Reports · 2023 · 43 citations · Full text

Pharmacy, Oncology, Pharmacology +17